Dinaciclib enhances natural killer cell cytotoxicity against acute myelogenous leukemia

Hyun Don Yun, Dawn K. Schirm, Martin Felices, Jeffrey S. Miller, Craig E. Eckfeldt

Research output: Contribution to journalArticlepeer-review

3 Scopus citations
Original languageEnglish (US)
Pages (from-to)2448-2452
Number of pages5
JournalBlood Advances
Volume3
Issue number16
DOIs
StatePublished - Aug 27 2019

Bibliographical note

Funding Information:
Acknowledgments This work was supported by the University of Minnesota Masonic Cancer Center and Academic Health Center Flow Cytometry Resource, which are supported by the National Institutes of Health,

Funding Information:
This work was supported by the University of Minnesota Masonic Cancer Center and Academic Health Center Flow Cytometry Resource, which are supported by the National Institutes of Health, National Cancer Institute (P30CA77598), Minnesota Masonic Charities, and the Killebrew-Thompson Memorial Fund. C.E.E. was supported by the Masonic Cancer Center, University of Minnesota, and an American Cancer Society Mentored Research Scholar Grant (MRSG-18-223-01-LIB). H.D.Y. was supported by a National Institutes of Health, National Heart, Lung, and Blood Institute Hematology Research Training Grant (T32HL007062).

Cite this